Sonali M. Smith, MD, discusses the current understanding of mantle cell lymphoma and how this understanding has evolved over recent years to understand different subsets of the disease that may require different frontline treatment for patients.
Videos
Ragini Kudchadkar, MD, discusses the overall prognosis of patients with ocular melanoma.
Shaji K. Kumar, MD, discusses how patients with multiple myeloma respond to different types of therapy.
Michael R. Charlton, MD, MBBS, discusses different types of therapy and trials in the hepatocellular carcinoma setting right now.
A 59-Year-Old Woman With HER2+ De Novo Metastatic Breast Cancer
Follicular Lymphoma
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Dr Mayer on Giredestrant's Success in Early Breast Cancer
2
PLT012 Receives IND Clearance from FDA for Solid Tumors
3
FDA Approves T-DXd Plus Pertuzumab for HER2-Positive Breast Cancer
4
Sacituzumab Govitecan: Elevating Quality of Life in First-Line TNBC
5